People / Staff

Jaume Català Mora

Search publications

Publications

  • Grigorovski N, Lucena E, Mattosinho C, Parareda A, Ferman S, Català-Mora J and Chantada G.

    Use of intra-arterial chemotherapy for retinoblastoma: results of a survey

    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY . 7(4): 726-730. Number of citations: 43

    [doi:10.3980/j.issn.2222-3959.2014.04.26]

  • Parareda A, Català-Mora J, Carcaboso AM, Sola T, Cruz-Martínez O, Díaz J, Salvador-Hernandez H, de Torres C, Álvarez-Sampons A, Suñol M, Vinent-Genestar J, Guimaraens L, Prat-Bartomeu J and Mora J.

    Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study

    ACTA OPHTHALMOLOGICA . 92(3): 209-215. Number of citations: 27

    [doi:10.1111/aos.12295]

  • Padrón-Pérez N and Català-Mora J.

    [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].

    JOURNAL FRANCAIS D OPHTALMOLOGIE . 37(2): 176-176.

    [doi:10.1016/j.jfo.2013.05.021]

  • Caminal JM, Mejia K, Masuet-Aumatell C, Arias L, Piulats JM, Gutierrez C, Pera J, Català-Mora J, Rubio M and Arruga J.

    Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.

    AMERICAN JOURNAL OF OPHTHALMOLOGY . 156(2): 334. Number of citations: 22

    [doi:10.1016/j.ajo.2013.03.036]

  • Caminal JM, Mejia-Castillo KA, Arias L, Català-Mora J, Rubio M, Garcia P, Pujol O and Arruga J.

    Subthreshold transpupillary thermotherapy in management of foveal subretinal fluid in small pigmented choroidal lesions.

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES . 33(1): 194-199. Number of citations: 6

    [doi:10.1097/IAE.0b013e3182618c06]

  • Català-Mora J, Díaz-Cascajosa J, Ferreruela-Sanfeliu G, Castany-Aregall M, Prat-Bartomeu J and García-Arumí J.

    23-G pars plana vitrectomy, lensectomy, and artisan IOL implantation for the management of nontraumatic ectopia lentis: a new iris enclavation technique for iris claw lens.

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES . 32(6): 1214-1216. Number of citations: 5

    [doi:10.1097/IAE.0b013e31824d4f06]

  • Arias L, Roman I, Masuet-Aumatell C, Rubio MJ, Caminal JM, Català-Mora J and Pujol O.

    One-year results of a flexible regimen with ranibizumab therapy in macular degeneration: relationship with the number of injections.

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES . 31(7): 1261-1267. Number of citations: 20

    [doi:10.1097/IAE.0b013e318207d152]

  • Castany M, Jordi I, Català-Mora J, Gual A, Morales M, Gasull X and Pintor J.

    Glaucoma patients present increased levels of diadenosine tetraphosphate, Ap(4)A, in the aqueous humour.

    EXPERIMENTAL EYE RESEARCH . 92(3): 221-226. Number of citations: 23

    [doi:10.1016/j.exer.2010.12.004]

  • Lorenzo D, Arias L, Alcubierre R, Pujol O, Caminal JM, Rubio M, Català-Mora J, Garcia-Bru P and Arruga J.

    Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month follow-up.

    Ophthalmologica . 226(3): 103-109. Number of citations: 10

    [doi:10.1159/000328980]

  • Arias L, Caminal JM, Badia MB, Rubio MJ, Català-Mora J and Pujol O.

    Intravitreal infliximab in patients with macular degeneration who are nonresponders to antivascular endothelial growth factor therapy.

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES . 30(10): 1601-1608. Number of citations: 50

    [doi:10.1097/IAE.0b013e3181e9f942]